Chromosome Enumeration Probes Market
Chromosome Enumeration Probes (CEP) are chromosome-specific FISH probes that hybridize to highly ... Read More
According to the National Institutes of Health (NIH), precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.
This report contains market size and forecasts of Artificial Intelligence in Precision Medicine in Global, including the following market information:
Global Artificial Intelligence in Precision Medicine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Artificial Intelligence in Precision Medicine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hardware Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Artificial Intelligence in Precision Medicine include Intel AI, IBM, GE Healthcare, Thermo Fisher Scientific, Qiagen, Berg Health and Medasense Biometrics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Artificial Intelligence in Precision Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Artificial Intelligence in Precision Medicine Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Artificial Intelligence in Precision Medicine Market Segment Percentages, by Type, 2021 (%)
Hardware
Software
Services
Global Artificial Intelligence in Precision Medicine Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Artificial Intelligence in Precision Medicine Market Segment Percentages, by Application, 2021 (%)
Oncology
Neurosciences
Immunology
Respiratory
Others
Global Artificial Intelligence in Precision Medicine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Artificial Intelligence in Precision Medicine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Artificial Intelligence in Precision Medicine revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Artificial Intelligence in Precision Medicine revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Intel AI
IBM
GE Healthcare
Thermo Fisher Scientific
Qiagen
Berg Health
Medasense Biometrics
Chromosome Enumeration Probes (CEP) are chromosome-specific FISH probes that hybridize to highly ... Read More
Fluorescence in situ Hybridization (FISH) products for the effective and rapid identification of ... Read More
This report contains market size and forecasts of Microdeletion Probes in global, including the f ... Read More
Fluorescent in situ hybridization (FISH) is a molecular cytogenetic technique that uses fluoresce ... Read More